Good mRNA vaccine news this morning! Ben Osborn, the UK head of Pfizer, said they do not expect to have to change their vaccine to handle SARS-CoV-2 variants B.1.1.17 and B.1.351 due to no drop in efficacy! Let’s talk about variants, vaccines, and why you shouldn’t panic. 🧵
Firstly, we can agree media response to the variants has been overblown and become a huge source of misinformation unfortunately. For some context: you are going to read and hear about a TON of variant viruses, because viruses mutate by nature. Not every single one is a concern.
While I know it’s scary and a lot is “unknown,” a couple of amino acids is not the same a whole whole new virus strain in the way that we’ve been taught to think about influenza. RNA viruses by nature mutate more readily than DNA viruses. Not to mention, SARS-CoV-2 doesn’t
necessarily mutate at a fast rate, it’s just transmitting a lot. What is happening, often times, as I have discussed before, is selective pressure. As the virus transmits it learns how to get better at transmitting. That’s why you might hear that the newest variant is circulating
faster than the last variant. They strive to alter their fitness by improving their rate of transmission. Their goal is to infect as many hosts as possible. But, don’t be panicked, as I said before, it will take a large amount of genetic diversity to completely make the
current vaccines useless and here is why: unlike monoclonal antibody therapies, vaccines (especially those utilizing the whole spike protein) make polyclonal antibody responses. This means that the antibodies you make after vaccination will be able to bind the coronavirus
spike in multiple places not just one. When these vaccines were developed, we decided to target the entire spike protein and smothered it with antibodies from every possible angle. So right here, you have strong neutralizing antibody titer data reassuring these mRNA vaccines will
work against these variants (that includes Moderna, of course). Even when we were faced with the D614G mutation we somewhat created a cushion effect, and it has worked out well in our favor in the face of these new variants and their efficacy against them.
biorxiv.org/content/10.110…
Next, we added this all to mRNA-elicited T-cell responses. If you have read my threads you can see I am a HUGE advocate of T-cells. Why? Because they’re what prevents us from experiencing severe disease and protect us from future variants.
See: nature.com/articles/d4158…
I also want to mention, it’s not just our mRNA vaccines that can claim prevention from severe disease and hospitalization- it’s ALL of the current vaccines. Data from J&J, Novavax, and AstraZeneca in areas where B.1.351 accounted for 95% of their viral strains demonstrated this.
Lastly, while data is still being collected we have plenty of reason to believe asymptomatic infection and therefore transmission can be reduced through our vaccines. I have a thread I am currently writing up on the subject and Novavax so get ready for some promising data.
So, in the end I don’t want anyone to panic about these variants. These will happen. What works in our favor is we have several vaccines that are effective against them, whether it’s through initial B-cell neutralizing antibody response, T-cell mediated immune response, or both.
I should mention. It’s not just the media. It’s a lot of experts I am disappointed in who have gotten addicted to attention and RTs. No, we aren’t facing an apocalypse. No, this isn’t going to last 10 years. The end of this year is looking bright and next year even brighter.
Should you need more information and context please do check out this thread.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Mac n’ Chise 🧬🧫🦠

Mac n’ Chise 🧬🧫🦠 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @sailorrooscout

15 Feb
Certain “experts” should be quite ashamed for pushing fear mongering tweets and using misleading studies to fit their rhetoric concerning the efficacy of these vaccines. Since they rely on the fact most will not understand the studies since it’s not in layman’s terms allow me. 🧵
Firstly, the conclusions being drawn from this study and this “expert” is that the B.1.1.7 and B.1.351 variants would render these vaccines ineffective. This is highly unlikely. It will take a large amount of genetic diversity to completely render the current vaccines useless.
Not to mention Ding is using an older study to push this rhetoric when Pfizer and Moderna have recently established their vaccines will be effective against these variants. Perhaps someone should pass THOSE studies onto him. For the record, if you’re going to claim these vaccines
Read 14 tweets
15 Feb
More promising mRNA vaccine data!
This time from Moderna. A new Phase II study shows that half-doses (50 μg) of our vaccine appear to be as effective as full doses (100 ug) at eliciting robust immune responses in the form of neutralizing antibodies.🧵
sciencedirect.com/science/articl…
Participants were stratified into two age cohorts (≥18-<55 and ≥55) and were randomly assigned (1:1:1) to either 50 or 100 µg of mRNA-1273, or placebo administered as two intramuscular injections 28 days apart.
The primary outcomes were safety, reactogenicity, and immunogenicity assessed by anti-SARS-CoV-2-spike binding antibody level (bAb). Secondary outcome was immunogenicity assessed by SARS-CoV-2 neutralizing antibody (nAb) response. Participants had no history of infection.
Read 10 tweets
11 Feb
The importance of T-cell immunity!
A recent study has found that after one dose of Pfizer’s vaccine, patients had a strong T-cell response, and a boosted antibody response after their second dose. This is good news for many reasons so let’s read up. 🧵
researchsquare.com/article/rs-226…
This study found that people’s antibodies were moderately effective against the original strain after their first dose of Pfizer’s vaccine, less effective against the B.1.1.7 variant, and were unable to neutralize the B.1.351 variant. Read what I said, that’s only after ONE dose.
However, they had strong T-cell responses against ALL known variants after the first dose. So why is this important? To recap, T-cells stimulate B-cells to make antibodies. Antibodies are just your first line of defense which is what is initiated when you get a vaccine.
Read 17 tweets
11 Feb
Want to get back to normal? Get vaccinated when you can. The purpose of vaccination is to bring the severity level of this virus down to the level of a benign one. It’s about controlling and reducing community spread while we work on proving these vaccines prevent transmission.
In the meantime, yes, you will have to continue to wear your mask until others catch up. You can do that. We all can. The more people vaccinated, the more restrictions will be lifted. The more people vaccinated, the less we will see hospital systems overwhelmed. The more people
vaccinated the faster we reach some normalcy. This is not about individual risk anymore. This is about community spread. It always has been. I’m going to tell you what the majority of media is not because if they did, you would have no more reason to tune in.
Read 6 tweets
10 Feb
A very encouraging study done on our mRNA vaccines! Pfizer and Moderna vaccines provided strong immune responses against variant B.1.351 first identified in South Africa in those who recovered from previous SARS-CoV-2 infections with a SINGLE dose.
medrxiv.org/content/10.110…
Individuals who were previously infected with SARS-CoV-2 displayed weak neutralizing activity not only against the original strain but variant B.1.351 as well (4-8 months post infection; remember antibodies from natural infection eventually wane over time). However, immunization Image
with a single dose of either mRNA vaccine elicited a robust antibody response that boosted neutralizing titers against the original strain by approximately 1000-FOLD. More importantly, vaccination elicited a robust neutralizing antibody response against B.1.351, although
Read 8 tweets
8 Feb
Let’s talk about immunity and why it’s important to take certain factors into consideration when we look at these studies and maybe why the most recent one on AstraZeneca’s effectiveness on the B.1.351 is a tad bit bothersome. For starters this beauty wasn’t tweeted initially.
See that last bullet point? The one of T-cell immunity. Yeah, that’s vital. Why? The study failed to discuss this aspect. You cannot disregard T-cells in the same breath you are discussing B-cells, vaccines and their respective induced antibody responses. It’s a package deal.
T-cells help protect against severe disease. Their analysis shows 76 out of 87 TCB sites (87%) are NOT impacted by the mutations seen in B.1.351. What does this mean? It means the T-cell response generated by AstraZeneca’s vaccine should be highly effective against this variant.
Read 14 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!